Answers are grounded in this paper and cite their sources.
Cohort study examines outcomes in individuals with hidradenitis suppurativa using GLP-1 receptor agonists, suggesting implications for clinical management.
This cohort study examines mortality, major cardiovascular events, and systemic complications in persons with hidradenitis suppurativa taking glucagon-like peptide-1 (GLP-1) receptor agonists.
No takes yet. Share an insight, caveat, or question.
Jastrząb-Miśkiewicz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: